Alberto J. Espay

2002–2025 年に発表

別表記
Alberto J Espay
204
論文数
19,083
被引用数
81
h 指数
188
i10 指数

被引用数

Alberto J. Espay の年別被引用数2003 年: 被引用 7 件2004 年: 被引用 11 件2005 年: 被引用 5 件2006 年: 被引用 11 件2007 年: 被引用 22 件2008 年: 被引用 35 件2009 年: 被引用 13 件2010 年: 被引用 22 件2011 年: 被引用 33 件2012 年: 被引用 33 件2013 年: 被引用 51 件2014 年: 被引用 66 件2015 年: 被引用 106 件2016 年: 被引用 134 件2017 年: 被引用 150 件2018 年: 被引用 199 件2019 年: 被引用 644 件2020 年: 被引用 925 件2021 年: 被引用 967 件2022 年: 被引用 884 件2023 年: 被引用 684 件2024 年: 被引用 1,192 件2025 年: 被引用 638 件2026 年: 被引用 21 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,918 件、この内訳の 20.5%イギリス: 引用元論文 867 件、この内訳の 9.3%イタリア: 引用元論文 819 件、この内訳の 8.8%ドイツ: 引用元論文 634 件、この内訳の 6.8%中国: 引用元論文 516 件、この内訳の 5.5%カナダ: 引用元論文 463 件、この内訳の 5%スペイン: 引用元論文 316 件、この内訳の 3.4%オーストラリア: 引用元論文 301 件、この内訳の 3.2%オランダ: 引用元論文 299 件、この内訳の 3.2%フランス: 引用元論文 293 件、この内訳の 3.1%スウェーデン: 引用元論文 215 件、この内訳の 2.3%スイス: 引用元論文 186 件、この内訳の 2%
0%20.5%その他 26.9%

分野

  • Medicine70.9%
  • Neuroscience10.8%
  • Biochemistry, Genetics and Molecular Biology6.2%
  • Health Professions5.2%
  • Computer Science1.6%
  • Psychology1.6%
  • その他3.7%

トピック

  • Parkinson's Disease Mechanisms and Treatments17%
  • Neurological disorders and treatments11.3%
  • Balance, Gait, and Falls Prevention3.3%
  • Botulinum Toxin and Related Neurological Disorders2.5%
  • Psychosomatic Disorders and Their Treatments2.4%
  • Alzheimer's disease research and treatments2.1%
  • その他61.4%

共著者

全論文

検索で開く
  1. Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Movement Disorders 2023 被引用: 346

  2. Technology in Parkinson's disease: Challenges and opportunities

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Movement Disorders 2016 被引用: 657

  3. Long-term unsupervised mobility assessment in movement disorders

    著者: , , , , , , , , , , , , , , , - The Lancet Neurology 2020 被引用: 326

  4. Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders

    著者: , , , , , , , , , , , , , , - JAMA Neurology 2018 被引用: 755

  5. Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mastura Wahedi, Katrina Wakeman, Alberto J. Espay, Julia Brown, Christina Wurzelbacher, Steven A. Gunzler, Elisar Khawam, Camilla Kilbane, Meredith Spindler, Megan Engeland, Arjun Tarakad, Matthew J. Barrett, Leslie Cloud, Virginia Norris, Zoltán Mari, Kara J. Wyant, Kelvin L. Chou, Angela Stovall, Cynthia Poon, Tanya Simuni, Kyle Tingling, Nijee Luthra, Caroline Tanner, Eda Yılmaz, D. B. Romero, Karen Thomas, Leslie Matson, Lisa C. Richardson, Michelle Fullard, Jeanne Feuerstein, Erika Shelton, David Shprecher, Michael Callan, Andrew Feigin, Caitlin Romano, Martina Romain, Michelle Shum, Erica Botting, Leigh Harrell, Claudia Rocha, Ritesh Ramdhani, Joshua Gardner, Ginger Parker, Victoria Ross, Steve J. Stephen, Katherine Fisher, Jeremy R. Edgerton, Jesse M. Cedarbaum, Robert Rubens, Jaya Padmanabhan, Diane Stephenson, Brian Severson, Michael Merickel, Daniel Jackson Amato, Thomas L. Carroll - npj Parkinson s Disease 2023 被引用: 91

  6. Neuroimaging in Functional Neurological Disorder: State of the Field and Research Agenda

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - NeuroImage Clinical 2021 被引用: 198

  7. A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies

    著者: , , , , , , , , , , , , , , , , - Movement Disorders 2019 被引用: 331

  8. Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts

    著者: , , , , , , , , , - Annals of Neurology 2018 被引用: 340

  9. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

    著者: , , , , , , , , , , , , , , - The Lancet Neurology 2013 被引用: 696

  10. Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Hauser, Christopher G. Goetz, Mark S. LeDoux, Vanessa K. Hinson, Rajeev Kumar, Alberto J. Espay, Joohi Jimenez‐Shahed, Christine Hunter, Chadwick W. Christine, Aaron Daley, Maureen A. Leehey, Joy Antonelle de Marcaida, Joseph H. Friedman, Albert Y. Hung, Grace Bwala, Irene Litvan, David K. Simon, Tanya Simuni, Cynthia Poon, Mya C. Schiess, Kelvin L. Chou, Ariane Park, Danish Bhatti, Carolyn Peterson, Susan R. Criswell, Liana S. Rosenthal, Jennifer Durphy, Holly A. Shill, Shyamal H. Mehta, Anwar Ahmed, Andres Deik, John Y. Fang, Natividad Stover, Lin Zhang, Richard B. Dewey, Ashley Gerald, James T. Boyd, Emily Houston, Valerie Suski, Sherri Mosovsky, Leslie Cloud, Binit Shah, Marie Saint‐Hilaire, Raymond James, S. Elizabeth Zauber, Stephen G. Reich, David Shprecher, Rajesh Pahwa, April Langhammer, Kathrin LaFaver, Peter A. LeWitt, Patricia L. Kaminski, John L. Goudreau, Doozie Russell, David Houghton, Ashley LaRoche, Karen Thomas, Martha McGraw, Zoltan Mari, Carmen Serrano, Karen Blindauer, Marcie Rabin, Roger Kurlan, John C. Morgan, Michael J. Soileau, Melissa Ainslie, Iván Bódis-Wollner, Ruth B. Schneider, Cheryl Waters, Amber Servi Ratel ほか 11 名 - JAMA 2021 被引用: 158

  11. Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melissa J. Armstrong, Rob M. A. de Bie, Emmanuel Roze, Janis M. Miyasaki, Robert A.Hauser, Alberto J. Espay, Justin P. Martello, Julie Gurwell, Lori Billinghurst, Kelly Sullivan, Michael S. Fitts, Nicholas Cothros, Deborah A. Hall, Miriam Rafferty, Lynn Hagerbrant, Tara Hastings, Mary Dolan O’Brien, Heather Silsbee, Gary Gronseth, Anthony E. Lang - Neurology 2021 被引用: 184

  12. Redefining Bradykinesia

    著者: , , , , , - Movement Disorders 2023 被引用: 81

  13. Parkinson’s Disease Subtypes: Critical Appraisal and Recommendations

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Parkinson s Disease 2021 被引用: 134

  14. Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations

    著者: , - Movement Disorders 2018 被引用: 362

  15. High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis

    著者: , , , , , , , , , , , , , - EClinicalMedicine 2021 被引用: 128

  16. Initiation of pharmacological therapy in Parkinson's disease: when, why, and how

    著者: , , , , - The Lancet Neurology 2020 被引用: 203

  17. Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marek Balaz, Marta Blazuez Estrada, Andrzej Bogucki, James T. Boyd, Laura Buyan Dent, Camille Carroll, Giovanni Castelnovo, Martinez Castrillo, K Ray Chaudhuri, Jeffrey W. Cooney, Anne-Gaëlle Corbillé, Esther Cubo Delgado, Téodor Danaila, Rob De Bie, Joy Antonelle De Marcaida, Maria Francesca De Pandis, Sophie Dethy, Rohit Dhall, Ruth Djaldetti, John Duda, Franck Durif, Borrue Fernandez, Yeva Fernandez, Stephen Flitman, Eric Freire Alvarez, Caroline Giordana, John L. Goudreau, Francisco Grandas Pérez, Robert A Hauser, David Houghton, Robert Hutchman, Arnaldo Isa, Jorge L. Juncos, S Kanchana, Iryna Karaban, Gabriela Kłodowska-Duda, Norbert Kovacs, Dariusz Koziorowski, J. Kulisevsky Bojarski, Rajeev Kumar, Kore Liow, Vered Livneh, Juan Lopez Lozano, Lan Luo, N. V. Lytvynenko, Irene Malaty, Roberto Marconi, Ana Raquel Marques, Irene Martínez‐Torres, Aashoo Mentreddi, Pablo Mir Rivera, Francesca Morgante, Sergii Moskovko, Stephen Mullin, Marshall Nash, Y. N. Neryanova, Marco Onofrj, Jill L. Ostrem, Claudio Pacchetti, Neepa Patel, Nicola Pavese, Clelia Pellicano, Manuela Pilleri, Dimitry Pokhabov, Gonzalo J. Revuelta, Margarida Rodrigues, Ramon L. Rodriguez, Monika Rudzińska, Nighat Sarwar, Julie Schwartzbard ほか 23 名 - The Lancet Neurology 2024 被引用: 71

  18. The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes

    著者: , , , , , , , , , , , - Journal of Alzheimer s Disease 2023 被引用: 53

  19. Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study over 12 months

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Camila Kilbane, Meredith Spindler, Matthew J. Barrett, Zoltan Mari, Liliana Dumitrescu, Kara J. Wyant, Kelvin L. Chou, Cynthia Poon, Tanya Simuni, Karen Williams, Nijee Luthra Caroline Tanner, Eda Yılmaz, Jeanne Feuerstein, David Shprecher, Andrew Feigin, Erica Botting - npj Parkinson s Disease 2024 被引用: 55

  20. Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2019 被引用: 267

  21. Lecanemab and Donanemab as Therapies for Alzheimer's Disease: An Illustrated Perspective on the Data

    著者: , , - eNeuro 2024 被引用: 78

  22. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Movement Disorders 2015 被引用: 207

  23. Feasibility and utility of a clinician dashboard from wearable and mobile application Parkinson's disease data

    著者: , , , , , , , , , - npj Digital Medicine, npj Digit. Medicine 2019 被引用: 68

  24. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

    著者: , , , , , , , , , , , , , , , , , , - Movement Disorders 2015 被引用: 307